Complion collected funding from investors including the multi-university-backed Ohio Innovation Fund for its regulatory compliance software platform catered to sites conducting clinical research.
Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.
The commercialisation firm will cut cash operating expenses by more than 40% year-on-year, while SciFluor Life and Precision Biopsy received $9m in financing between them.
Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a Boston University-operated body and a $8.5m series A round.
Based on Lund University research, group B streptococcus vaccine developer Minervax has now raised $11.4m from investors including Novo.
University of Cambridge’s affiliate patient capital fund has returned to take part in an $8.4m round for video content management platform Imagen after previously investing in 2014 and 2016.
The seven-digit investment by BE Beteiligungen Fonds will help Salzburg e-commerce search spinout Findologic accelerate its international expansion and introduce new product features.
IP Group has poured more funding into Istesso, whose treatment for rheumatoid arthritis traces its roots to an Aberdeen spinout, to drive immuno-metabolism therapies for autoimmune diseases.